Navigation Links
UCLA, Caltech research on immune-cell therapy could strengthen promising melanoma treatment
Date:3/22/2013

A new study of genetically modified immune cells by scientists from UCLA and the California Institute of Technology could help improve a promising treatment for melanoma, an often fatal form of skin cancer.

The research, which appears March 21 in the advance online edition of the journal Cancer Discovery, was led by James Heath, a member of UCLA's Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research and UCLA's Jonsson Comprehensive Cancer Center. Heath is a professor of molecular and medical pharmacology at UCLA and also holds the Elizabeth W. Gilloon Chair in Chemistry at Caltech.

The melanoma treatment uses T cells immune cells that play a major role in fighting infection taken from patients with melanoma. The cells are then genetically modified in the laboratory so that when they are reintroduced into a patient's bloodstream, they specifically attack melanoma tumors. In early clinical trials, this treatment was shown to shrink tumors dramatically in many patients, but the positive effects were often short-lived.

The UCLA and Caltech researchers found that after the engineered T cells were returned to patients, their efficacy faded within two to three weeks. Surprisingly, however, once the engineered cells were no longer effective, a new group of non-engineered T cells arose that had a similar tumor-killing effect that lasted even longer, the scientists discovered.

Using newly developed nanotechnology chips to perform multidimensional and multiplexed immune-monitoring assays, the researchers were able to examine at high resolution single engineered T cells taken at different times from patients undergoing the therapy, each of whom had a different level of response to the treatment.

"The engineered T cells did not recover their tumor-killing effect," Heath said, "but after one month, another group of T cells appeared that did have tumor-killing effects for another 90 days. Th
'/>"/>

Contact: Shaun Mason
smason@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Scientists from UCLA, Israels Technion uncover brains code for pronouncing vowels
2. Michigan Lupus Foundation Texas Hold 'Em Tournament Raises Thousands for Lupus Support, Education & Research
3. Frisco Institute for Reproductive Medicine Welcomes China Research Team
4. Research explores links between physical and emotional pain relief
5. Multiple sclerosis research: The thalamus moves into the spotlight
6. Dr. Roger D. Weiss earns Hazeldens Dan Anderson Research Award
7. Patient Wishes Should Guide End-of-Life Care, Researchers Say
8. Scripps Research study underlines potential of new technology to diagnose disease
9. Researchers new method may sharpen microscopic images
10. New web portal on health research in Europe
11. Researchers tackle physician challenge of correctly ordering laboratory tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently ... thrilled to have it lead the wedding dress industry into ... prom dresses for the global market. , “The CEO of ... he focuses on continuing the goal of operational excellence and ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently released ... website of AngelWeddingDress.com to find more details. , ... for a bridal party. AngelWeddingDress offers a variety of ... maternity wedding dresses are specially designed for 2015. , ...
(Date:1/22/2015)... 2015 Thousand of GranuFlo lawsuits ( ... its GranuFlo and NaturaLyte dialysis concentrates continue to move ... District Court, District of Massachusetts, Bernstein Liebhard LLP reports. ... has remanded a case filed by the state of ...
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 Joan ... and keynote speaker at the upcoming 32nd Annual ... ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , shares ... would have gone undetected if she had not followed ...
(Date:1/22/2015)... Palm City, Florida (PRWEB) January 22, 2015 ... use cold therapy machine with patented IsoTube design to treat ... has introduced the most progressive and easy to use ... help treat post-operative and sports related orthopedic and muscle injuries. ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
... have been able to bring an improvement in the ... pulmonary disease (COPD) by teaching them to play the ... of a pulmonary rehabilitation class at the university. The ... chronic obstructive pulmonary disease can focus on their breathing ...
... from osteoporosis from loss of bone mass, there may be ... that it can help improve bone mass in women who ... the principal recommendations for preventing and treating the loss of ... always possible, particularly for the frail., ,An experimental device ...
... of Archives of Internal Medicine said that doctors might ... bio-terrorism that may be caused by smallpox, anthrax, botulism ... tested were unable to correctly diagnose diseases caused by ... test scores improved dramatically for the same physicians after ...
... you are a smoker, says a new study. ... Forest University School of Medicine// examined the relationship between ... study, reports science portal EurekAlert. ,They compared the ... among those who had never smoked. ,Twenty-five percent ...
... the excess weight that one has to carry like excess ... best way is that adopted earlier that is the basic ... Obesity is a big problem these days. , ,Calorie ... of approach towards weight control. ,With so many dietary ...
... walnut sized gland present below the urinary bladder in males. ... that add volume to the semen//. Prostate cancer is the ... of cancer death in American men. The incidence of the ... to cancer prevention, an assessment of the risk factors is ...
Cached Medicine News:
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, ... Global Biotechnology, Inc. for the compounding, packaging and distributing of ... in the United States . ... capable of compounding naltrexone tablets in various strengths for individual ...
(Date:1/23/2015)...  HyGreen, Inc., a leader in hand hygiene monitoring, today ... a subsidiary of Ascendis Health Limited, in ... hundreds of millions of patients around the world are ... from patient to patient via the unwashed hands of ...
(Date:1/23/2015)... 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that the ... Lixte,s lead compound, LB‑100, is being conducted, has been expanded ... Kovach , M.D., the founder and President of Lixte, said ... a single site. Accrual of patients, however, was slower than ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... , INDIANAPOLIS, Oct. 21 , Higher volume drives revenue growth ... increase to $.86 (reported) or $1.20 (pro forma non-GAAP) Full-year 2009 EPS ... , Eli Lilly and Company (NYSE: LLY ) today announced financial ... per share data Third Quarter, ...
... Massachusetts, October 21 Shire plc,(LSE: SHP, NASDAQ: ... file a Biologics License Application (BLA) with the U.S.,Food ... replacement therapy for Fabry disease, by the end of ... for REPLAGAL, filed at the,request of FDA, has been ...
Cached Medicine Technology:Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 2Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 3Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 4Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 5Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 6Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 7Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 8Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 9Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 10Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 11Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 12Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 13Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 14Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 15Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 16Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 17Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 18Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 19Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 20Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance 21Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 3Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 4
... license agreement between Brook Brothers and ... Characterized by lightweight materials and a ... reflect the unique features of the ... product with classic style and affordable ...
... The new Eyewear collection is a ... and sophisticated in the House of Salvatore ... four mens, as well as up-dates of ... Florentine brand reassert themselves in a brilliant ...
... Vision eyewear includes three collections - Nike ... Ophthalmics, offering active lifestyle consumers the latest ... performance. The sun collections feature Nikes Max ... in a larger vision sweet spot for ...
... technology has redefined rimless collections forever.,The Airlock ... the end of each frame mounting. This ... bushing that mounts within the lens. When ... fit is created that far exceeds that ...
Medicine Products: